SEC Form 4 · accession 0001140361-15-010627

IDEXX LABORATORIES INC /DE · IDXX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Mar 4, 2015

Accepted (ET)

Mar 6, 2015 · 10:15 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000874716

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 4, 2015	M	2,372	$34.37	A	13,267	D
Common Stock	Mar 4, 2015	M	2,000	$53.31	A	15,267	D
Common Stock^F1	Mar 4, 2015	S	6,168	$158.4937	D	9,099	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$34.37	Mar 4, 2015	M	2,372	D	—	Feb 13, 2016	Common Stock	2,372	0	D
Non-Qualified Stock Option (right to buy)^F3	$53.31	Mar 4, 2015	M	2,000	D	—	Feb 13, 2017	Common Stock	2,000	14,168	D

F1The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $158.4650 to $158.5750, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,373 shares on 02/14/2010, 02/14/2011, 02/14/2012 and 02/14/2013, and the remaining 2,372 shares on 02/14/2014.
F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.